Form D · Biotechnology
Kura Oncology, Inc.
San Diego, CA · CIK 0001422143
Offering snapshot reported Feb 5, 2024 · SEC filing
- Reported sold
- $150M Offering amount: $150M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2024 | Initial | $150,000,808 | No comparison | 10 | SEC filing |
| Mar 19, 2015 | Initial | $91,691,679 | No comparison | 356 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.75M
- Finders' fees
- $0
- Form D file number
- 021-504346
Includes amounts receivable upon exercise of warrants to purchase common stock; such warrants have not yet been exercised.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 |
Source: Form D, filed Feb 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Teresa Bair | Executive |
| Helen Collins | Director |
| Stephen Dale | Executive |
| Kathleen Ford | Executive |
| Antonio Gualberto | Executive |
| Faheem Hasnain | Director |
| Heidi Henson | Executive |
| Yi Liu | Executive |
| Thomas Malley | Director |
| Annette North | Executive |
| Diane Parks | Director |
| Brian Powl | Executive |
| Pingda Ren | Executive |
| Carol Schafer | Director |
| Mary Szela | Director |
| Troy Wilson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12730 High Bluff Drive, Suite 400
San Diego, CA, 92130
San Diego, CA, 92130